tradmap

STIM Financials Neuronetics, Inc.

10 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 24.8% per year over the past 5 years.
  • Operating margin has expanded, at -21.1% in the latest year.

Financial health

  • Total debt ($66M) exceeds cash ($28M); net debt is $38M.
  • Total debt has grown slower than revenue (13.7% vs 24.8% per year).
  • Operating income covered interest expense -3.7× in the latest year.
  • The company is unprofitable; at its current free-cash-flow burn it has roughly 1.3 years of cash runway.
Revenue & net income
-$44M $53M $149M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
RevenueNet income
Margins (gross / operating / net)
-58% 10% 79% 0% 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
GrossOperatingNet
Free cash flow (CFO − capex)
-$34M -$17M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Free cash flow
Cash vs total debt
$0 $52M $105M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
CashTotal debt
Cash flow: operating / investing / financing
-$32M $33M $97M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $149M -$39M 48.5% -21.1% -$21M $66M $28M
2024 $75M -$44M 72.3% -46.2% -$32M $55M $18M
2023 $71M -$30M 72.5% -42.8% -$34M $59M $60M
2022 $65M -$37M 76.3% -53.8% -$34M $36M $70M
2021 $55M -$31M 78.9% -49.8% -$30M $35M $94M
2020 $49M -$27M 76.5% -45.3% -$29M $35M $49M
2019 $63M -$29M 75.4% -43.0% -$31M $31M $76M
2018 $53M -$24M 76.4% -37.6% -$22M $30M $105M
2017 $40M -$16M 76.2% -33.7% -$12M $30M $29M
2016 -$11M -$9M $17M

Valuation over time

How the market has priced STIM against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / sales (P/S)
0.0 2.3 4.6 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S

Frequently asked questions

Is STIM growing its revenue and profit?

Over the past 5 years, Neuronetics, Inc.'s revenue has grown 24.8% per year. These are computed facts, not advice.

How much debt does STIM have?

As of FY2025, Neuronetics, Inc. reported $66M of total debt against $28M of cash; operating income covered interest expense -3.7×.

What is STIM's profit margin?

In FY2025, gross margin was 48.5%, operating margin -21.1%, and net margin -26.1%.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.